Texas ChE Professor Jennifer Maynard and her research team have engineered “antibody-like” T cell receptors that can specifically stick to cells infected with cytomegalovirus, or CMV, a virus that causes lifelong infection in more than half of all adults by age 40. These receptors represent a new potential treatment option, could aid the development of … Read the rest »
Posts Tagged ‘Jennifer Maynard’
“Antibody-like” T Cell Receptors May Be New Potential Treatment for Cytomegalovirus (#CMV) and Brain Tumors
Alum Elected Vice Chair of the BIOTEC Section of the American Association of Pharmaceutical Scientists
Alumnus Tarik Khan (Ph.D. ’12) has been elected as the new vice chair of the Biotechnology Section of the American Association of Pharmaceutical Scientists (AAPS). Khan is a former student of the Maynard Lab Group.
“This recognition by his fellow scientists is a testament to the his ongoing contributions and leadership in the pharmaceutical field,” … Read the rest »
A team of researchers in the Cockrell School of Engineering at The University of Texas at Austin, including McKetta Department of Chemical Engineering professor Jennifer Maynard, have been awarded a $100,000 grant from the Grand Challenges Explorations initiative, a program funded by the Bill & Melinda Gates Foundation, to pursue research aimed at improving … Read the rest »
Texas ChE researchers recently published preclinical test results showing the use of antibodies in mice and baboons was successful in providing short-term immunity and an accelerated recovery from pertussis, also known as whooping cough. The findings, which were published in a paper on Dec. 2 in Science Translational Medicine, will help advance the treatment … Read the rest »
Ben Wendel (Georgiou Group)
A System Immunology Approach to the Development of Natural Immunity to Malaria
Ben’s research explores the progression of the immune system with age … Read the rest »
South by Southwest (SXSW) Interactive is hosting inventors, thought leaders and entrepreneurs at the festival’s UT Village Sunday, March 15 from 9:30 a.m.-6 p.m. at the Radisson Hotel & Suites in downtown Austin.
The event is an all-day showcase of innovation and expertise that offers visitors the chance to get a behind-the-scenes look at the … Read the rest »
Associate professor Jennifer Maynard’s research group is working to develop a therapeutic vaccine to treat whooping cough—a highly contagious and dangerous disease that causes an estimated 294,000 deaths annually worldwide, primarily among young, unvaccinated children. Whooping cough is on the rise in the United States, and in Texas cases have increased 79 percent in … Read the rest »
Abby Bassett was only four weeks old when what seemed to be a mild cold turned into a much harsher reality.
The newborn was diagnosed with pertussis, or whooping cough, a disease that claims the lives of 195,000 children across the globe annually.
Associate Professor Jennifer Maynard, the Laurence E. McMakin, Jr. Centennial Faculty Fellow, has teamed up with biotech company Synthetic Biologics, Inc. to develop a monoclonal antibody (mAb) therapy for the treatment of pertussis, commonly known as whooping cough.
Whooping cough causes an estimated 294,000 deaths annually worldwide, primarily among young, unvaccinated children. Recent reports … Read the rest »